122 related articles for article (PubMed ID: 2821514)
1. Antiferritin immunoglobulin therapy for treatment of hepatoma.
Held J; McLaughlin P
Oncol Nurs Forum; 1987; 14(5):27-31. PubMed ID: 2821514
[No Abstract] [Full Text] [Related]
2. [131I antiferritin in the treatment of hepatoma and Hodgkin's disease].
Cohen Y; Moroz H
Harefuah; 1986 Dec; 111(11):398-9. PubMed ID: 3028919
[No Abstract] [Full Text] [Related]
3. [Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
Une Y; Sato Y; Alam S; Nagabuchi E; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1993 Jan; 20(1):161-3. PubMed ID: 8380685
[No Abstract] [Full Text] [Related]
4. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Hellman S
J Clin Oncol; 1985 Dec; 3(12):1569. PubMed ID: 2999345
[No Abstract] [Full Text] [Related]
5. Antiferritin immunoglobulin therapy for treatment of hepatoma.
Bucholtz JD; Powers G; Wall S
Oncol Nurs Forum; 1988; 15(2):133-4. PubMed ID: 2451814
[No Abstract] [Full Text] [Related]
6. Recent progress in the treatment of hepatocellular carcinoma.
Roh MS
Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
[No Abstract] [Full Text] [Related]
7. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
[TBL] [Abstract][Full Text] [Related]
8. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
[TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy of malignant tumors of the liver].
Ducreux M; Lartigau E; Eschwege F; Etienne JP
Gastroenterol Clin Biol; 1995 Apr; 19(4):350-60. PubMed ID: 7672521
[No Abstract] [Full Text] [Related]
10. Antiferritin IgG antibody for isotopic cancer therapy.
Order SE; Klein JL; Leichner PK
Oncology; 1981; 38(3):154-60. PubMed ID: 6259569
[TBL] [Abstract][Full Text] [Related]
11. Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies.
Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):703-10. PubMed ID: 6256319
[No Abstract] [Full Text] [Related]
12. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
13. Dosimetry and treatment planning in radioimmunotherapy.
Leichner PK; Yang NC; Wessels BW; Hawkins WG; Order SE; Klein JL
Front Radiat Ther Oncol; 1990; 24():109-20; discussion 121-2. PubMed ID: 2160407
[No Abstract] [Full Text] [Related]
14. Hepatoma: model for radiolabeled antibody in cancer treatment.
Order SE; Klein JL; Leichner PK
NCI Monogr; 1987; (3):7-41. PubMed ID: 2434868
[TBL] [Abstract][Full Text] [Related]
15. Immunoradiotherapy for primary nonresectable hepatocellular carcinoma.
Sitzmann JV; Order SE
Surg Clin North Am; 1989 Apr; 69(2):393-400. PubMed ID: 2538937
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry.
Leichner PK; Klein JL; Garrison JB; Jenkins RE; Nickoloff EL; Ettinger DS; Order SE
Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):323-33. PubMed ID: 6268576
[No Abstract] [Full Text] [Related]
17. Adjuvant adoptive immunotherapy against hepatocellular carcinoma.
Takayama T; Sekine T; Kondo Y; Kakizoe T; Makuuchi M
Hepatology; 1998 Nov; 28(5):1436-7. PubMed ID: 9794935
[No Abstract] [Full Text] [Related]
18. Radiolabeled antibody therapy.
Bucholtz JD
Semin Oncol Nurs; 1987 Feb; 3(1):67-73. PubMed ID: 3031793
[No Abstract] [Full Text] [Related]
19. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
20. Combating hepatocellular carcinoma with an integrated approach.
Ho S; Johnson PJ; Leung WT; Lau WY
Chin Med J (Engl); 1999 Jan; 112(1):80-3. PubMed ID: 11593648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
